40V
SGXiX Biopharma Ltd
Health CareSingapore
Top 20 Shareholders
Top 20 shareholder data not yet available for this company.
We're expanding our SGX coverage — check back soon.
Substantial Holders
No substantial holder notices available for this company.
We're expanding our SGX coverage — check back soon.
Recent Insider Trades
1 net buyer
| Person | Date | Type | Shares | Value |
|---|---|---|---|---|
| Chan (Heng Fai Ambrose) | 5 Mar 2025 | buy | 1,192,800 | $22K |
| Chan (Heng Fai Ambrose) | 27 Nov 2024 | buy | 400,000 | $8K |
| Chan (Heng Fai Ambrose) | 26 Nov 2024 | buy | 103,800 | $2K |
| Chan (Heng Fai Ambrose) | 25 Nov 2024 | buy | 300,000 | $6K |
| Chan (Heng Fai Ambrose) | 20 Nov 2024 | buy | 1,151,000 | $25K |
| Chan (Heng Fai Ambrose) | 19 Nov 2024 | buy | 131,000 | $3K |
Price Chart
Insufficient price data
Key Metrics
P/E Ratio-
P/B Ratio1.22
EV/EBITDA-1.64
Dividend Yield-
ROE-25.1%
ROA-15.2%
Net Margin0.0%
Debt/Equity0.01
Net Debt/EBITDA-
FCF Yield-
Governance Score
-
SGX Code of Corporate Governance
StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.